TY - JOUR
T1 - Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages
AU - Ramana, Kota V.
AU - Srivastava, Satish K.
N1 - Funding Information:
This study was supported in part by NIH grants GM 71036 (to KVR) and DK 36118 (to SKS).
PY - 2006/11
Y1 - 2006/11
N2 - Aldose reductase (AR; AKR1B1) a member of aldo-keto reductase super family, that we had shown earlier mediates cytotoxic signals induced by high glucose, cytokines and growth factors, also mediates the inflammatory signals induced by Gram-negative bacterial endotoxin, lipopolysaccharide (LPS). Inhibition of AR by three distinct AR inhibitors sorbinil, tolrestat or zopolrestat suppressed the LPS-induced production of inflammatory cytokines such as TNF-α, IL-6, IL-1β, IFN-γ, and chemokine MCP-1 in murine peritoneal macrophages. Inhibition of AR also prevented the production of nitric oxide, and prostaglandin E2 and expression of iNOS and Cox-2 proteins. The LPS-induced DNA binding activity of NF-κB and AP1 were significantly inhibited by AR inhibitors, and this effect was mediated through the inhibition of phosphorylation of IκB-α, IKK α/β and PKC. These results suggest the therapeutic use of AR inhibitors as anti-inflammatory drugs.
AB - Aldose reductase (AR; AKR1B1) a member of aldo-keto reductase super family, that we had shown earlier mediates cytotoxic signals induced by high glucose, cytokines and growth factors, also mediates the inflammatory signals induced by Gram-negative bacterial endotoxin, lipopolysaccharide (LPS). Inhibition of AR by three distinct AR inhibitors sorbinil, tolrestat or zopolrestat suppressed the LPS-induced production of inflammatory cytokines such as TNF-α, IL-6, IL-1β, IFN-γ, and chemokine MCP-1 in murine peritoneal macrophages. Inhibition of AR also prevented the production of nitric oxide, and prostaglandin E2 and expression of iNOS and Cox-2 proteins. The LPS-induced DNA binding activity of NF-κB and AP1 were significantly inhibited by AR inhibitors, and this effect was mediated through the inhibition of phosphorylation of IκB-α, IKK α/β and PKC. These results suggest the therapeutic use of AR inhibitors as anti-inflammatory drugs.
KW - Aldose reductase
KW - Inflammation
KW - Lipopolysaccharide
KW - NF-κB
KW - Sepsis
UR - http://www.scopus.com/inward/record.url?scp=33847147251&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847147251&partnerID=8YFLogxK
U2 - 10.1016/j.cyto.2006.11.003
DO - 10.1016/j.cyto.2006.11.003
M3 - Article
C2 - 17174561
AN - SCOPUS:33847147251
SN - 1043-4666
VL - 36
SP - 115
EP - 122
JO - Cytokine
JF - Cytokine
IS - 3-4
ER -